Error loading player: No playable sources found
4580
Genetic Susceptibility and Beyond: Impact on GI Cancer Risk Stratification and Surveillance
Date
May 20, 2024
Tracks
Related Products
Irritable Bowel Syndrome Clinical
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Reducing CRC Incidence Through Screening and Surveillance
SOCIETY: AGA CRC screening and surveillance